Adenocarcinoma of the Prostate

Oncology·MeSH: Prostatic Neoplasms

9 drugs in development·3 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(4)

Phase 2(2)

Drug	Company
Antiandrogen Therapy	Royalty Pharma plc (RPRX)
triptorelin	KYNTRA BIO INC. (KYNB)

Phase 1(1)

Drug	Company
Androgen Deprivation Therapy	Janux Therapeutics, Inc. (JANX)

Phase 4(2)

Drug	Company
Androgen Deprivation Therapy	Royalty Pharma plc (RPRX)
Androgen-deprivation Therapy	Royalty Pharma plc (RPRX)

BioSniper tracks 9 drugs in development for Adenocarcinoma of the Prostate across 3 companies.

There are 6 clinical trials targeting Adenocarcinoma of the Prostate tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.